Concepedia

M. Capanu

MC

Statistics

Publications

4

Citations

385

H-Index

4

Active since

2009

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

M. Capanu is an author at Memorial Sloan Kettering Cancer Center specializing in chemotherapy, medicine, and oncology.

Publications per year

2009–2014

4

Publications

4

Phase II Trial of Hepatic Artery Infusional and Systemic Chemotherapy for Patients With Unresectable Hepatic Metastases From Colorectal Cancer

Michael I. D’Angelica, Camilo Correa‐Gallego, Philip B. Paty et al. · Annals of Surgery · 2014 · 242 citations · Full text

, , +17

Phase III Trial of Cetuximab, Bevacizumab, and 5-Fluorouracil/Leucovorin vs. FOLFOX-Bevacizumab in Colorectal Cancer

Leonard B. Saltz, Suprith Badarinath, Shaker R. Dakhil et al. · Clinical Colorectal Cancer · 2011 · 69 citations

, , +11

Random assignment multicenter phase II study of modified docetaxel, cisplatin, fluorouracil (mDCF) versus DCF with growth factor support (GCSF) in metastatic gastroesophageal adenocarcinoma (GE).

M. A. Shah, Shigeru Shibata, Ronald G. Stoller et al. · Journal of Clinical Oncology · 2010 · 46 citations

, , +9

Analysis of survival with modified docetaxel, cisplatin, fluorouracil (mDCF), and bevacizumab (BEV) in patients with metastatic gastroesophageal (GE) adenocarcinoma: Results of a phase II clinical trial

D. Kelsen, Minaxi Jhawer, D.H. Ilson et al. · Journal of Clinical Oncology · 2009 · 28 citations

, , +11

1–4 of 4